Evidence map›Paper›PMID 25659151›Full record

ArticlePloS one2015

Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.

Wei-Chun Hsu, Miroslav N Nenov, Alexander Shavkunov, Neli Panova, Ming Zhan, Fernanda Laezza

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 54 citations in OpenAlex.

  1. Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Article
  3. OLUFF: a novel set of ground and excited state force field parameters of the emitting oxyluciferin species.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Voltage-Gated NaLife (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  10. Inhibition of the Akt/PKB Kinase Increases NaInternational journal of molecular sciences · 2022
    Article
  11. Article
  12. Review
  13. Differential Modulation of the Voltage-Gated NaFrontiers in molecular biosciences · 2021
    Article
  14. Article
  15. Article
  16. JAK2 regulates Nav1.6 channel function via FGF14Biochimica et biophysica acta. Molecular cell research · 2020
    Article
  17. Article
  18. Article
  19. Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wei-Chun HsuDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America; M.D./Ph.D. Combined Degree Program, University of Texas Medical Branch, Galveston, Texas, United States of America.
Miroslav N NenovDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Alexander ShavkunovDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Neli PanovaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Ming ZhanDepartment of Systems Medicine and Bioengineering, Weill Cornell Medical College, Methodist Hospital Research Institute, Houston, Texas, United States of America.
Fernanda LaezzaDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas, United States of America; Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Biomedical Engineering, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas, United States of America.
The University of Texas Medical Branch at Galveston · USMethodist Hospital · US

Funding

Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
NIMH NIH HHS R01 MH095995NIMH NIH HHS R01MH095995
6 · The paper itself

Abstract

Kinases play fundamental roles in the brain. Through complex signaling pathways, kinases regulate the strength of protein:protein interactions (PPI) influencing cell cycle, signal transduction, and electrical activity of neurons. Changes induced by kinases on neuronal excitability, synaptic plasticity and brain connectivity are linked to complex brain disorders, but the molecular mechanisms underlying these cellular events remain for the most part elusive. To further our understanding of brain disease, new methods for rapidly surveying kinase pathways in the cellular context are needed. The bioluminescence-based luciferase complementation assay (LCA) is a powerful, versatile toolkit for the exploration of PPI. LCA relies on the complementation of two firefly luciferase protein fragments that are functionally reconstituted into the full luciferase enzyme by two interacting binding partners. Here, we applied LCA in live cells to assay 12 kinase pathways as regulators of the PPI complex formed by the voltage-gated sodium channel, Nav1.6, a transmembrane ion channel that elicits the action potential in neurons and mediates synaptic transmission, and its multivalent accessory protein, the fibroblast growth factor 14 (FGF14). Through extensive dose-dependent validations of structurally-diverse kinase inhibitors and hierarchical clustering, we identified the PI3K/Akt pathway, the cell-cycle regulator Wee1 kinase, and protein kinase C (PKC) as prospective regulatory nodes of neuronal excitability through modulation of the FGF14:Nav1.6 complex. Ingenuity Pathway Analysis shows convergence of these pathways on glycogen synthase kinase 3 (GSK3) and functional assays demonstrate that inhibition of GSK3 impairs excitability of hippocampal neurons. This combined approach provides a versatile toolkit for rapidly surveying PPI signaling, allowing the discovery of new modular pathways centered on GSK3 that might be the basis for functional alterations between the normal and diseased brain.

Indexed as

AnimalsFibroblast Growth FactorsGenetic Complementation TestHEK293 CellsHippocampusHumansLuciferasesNAV1.6 Voltage-Gated Sodium ChannelNeuronsProtein Kinase InhibitorsProtein KinasesRatsSignal Transductionfibroblast growth factor 14Fibroblast Growth FactorsLuciferasesNAV1.6 Voltage-Gated Sodium ChannelProtein Kinase InhibitorsProtein KinasesSCN8A protein, humanScn8a protein, rat

Identifiers

PMID25659151
PMCPMC4319734
OpenAlexW2082578748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.